• Home
  • Mutual Funds
  • HDFC Pharma and Healthcare Fund Growth

HDFC Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

HDFC Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹100

AUM (Fund size)

₹2,611 Cr

Lock In Period

N/A

Expense Ratio

2.23

Exit Load

In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.No Exit Load is payable if units are redeemed / switchedout after 30 days from the date of allotment.

Benchmark

BSE Healthcare

HDFC Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M5.060.7113.13
6M20.152.3385.21
1Y20.304.55153.64
3Y0.0012.32278.05

Portfolio Analysis

  • Equity: 98.68%
  • Debt: 1.32%
  • Others
As on: 2026-05-31
View allocation % by

1. Sun Pharmaceutical Industries Ltd.9.20%
2. Divis Laboratories Ltd.8.02%
3. Lupin Ltd.5.45%
4. Cipla Ltd.4.92%
5. Acutaas Chemicals Limited4.50%
6. Alkem Laboratories Ltd.4.36%
7. Anthem Biosciences Limited4.15%
8. Ipca Laboratories Ltd.3.50%
9. Glenmark Pharmaceuticals Ltd.3.28%
10. Laurus Labs Ltd.3.17%
11. Neuland Laboratories Limited2.98%
12. Zydus Lifesciences Limited2.50%
13. Wockhardt Ltd.2.44%
14. Shilpa Medicare Ltd2.28%
15. Sai Life Sciences Limited1.78%
16. Eris Lifesciences Ltd1.61%
17. Rubicon Research Limited1.35%
18. Jubilant Pharmova Limited1.34%
19. Biocon Ltd.1.33%
20. Gland Pharma Ltd.1.19%
21. BAJAJ HEALTHCARE LIMITED0.73%
22. Novartis India Ltd.0.64%
23. Cohance Lifesciences Limited0.46%

1. Max Healthcare Institute Limited5.26%
2. Aster DM Healthcare Limited5.18%
3. Fortis Healthcare Limited3.41%
4. Krishna Institute Of Medical Sciences Limited3.16%
5. Global Health Limited3.08%
6. Vijaya Diagnostic Centre Limited2.70%
7. Metropolis Healthcare Ltd.2.54%
8. Thyrocare Technologies Ltd.1.54%

About Fund HDFC Pharma and Healthcare Fund Growth

HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹2,611 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.23. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Nikhil Mathur

Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
UTI Innovation Fund Growth0767.04 CR2.38
Edelweiss Business Cycle Fund Growth01477.93 CR2.69
HDFC Pharma and Healthcare Fund Growth02611.33 CR2.23
HDFC Defence Fund Growth510529.25 CR1.8
Nippon India Taiwan Equity Fund Growth31191.72 CR2.6
Fund Name1Y3Y
This FundUTI Innovation Fund Growth0.13650
This FundEdelweiss Business Cycle Fund Growth-1.66680
This FundHDFC Pharma and Healthcare Fund Growth20.3050
This FundHDFC Defence Fund Growth18.0352174.1085
This FundNippon India Taiwan Equity Fund Growth150.1852262.7182

HDFC Pharma and Healthcare Fund Growth FAQs

HDFC Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of HDFC Pharma and Healthcare Fund Growth is 2.23. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

HDFC Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 5.06%
  • 6 Months : 20.15%
  • 1 Year : 20.30%
  • 3 Years : 0.00%
Returns of HDFC Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 20.79 as on Jul 14,2026. Since inception, the return has been 0.00%.

You can invest in HDFC Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of HDFC Pharma and Healthcare Fund Growth is ₹2,611 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in HDFC Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.